Aurlumyn Injection, Solution
Product Images NDC 50633-340

3 FDA label images from Btg International Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aurlumyn (NDC 50633-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aurlumyn 01)

Chemical Structure (Aurlumyn 01)
Chemical structure diagram of iloprost, the active ingredient in AURLUMYN injection solution 100 mcg/mL by BTG International Inc. The structure shows key functional groups and stereochemistry characteristic of iloprost.*
FDA Label Image

Carton Label (Aurlumyn 02)

FDA Label Image

Vial Label (Aurlumyn 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.